Sk Biopharmaceuticals Co., Ltd.

Sk Holdings Co., Ltd.

Han-Ju Yi

Ki-Ho Lee

Joon Heo

Yu-Jin Shin

Cheol-Young Maeng

Jin-Yong Chung

Young-Soon Kang

Eun-Hee Chae

Yong Moon Choi

Eun Hee Chae

Byong Sung Kwak

Sang Mi Chae

Young Soon Kang

Hong Sik Moon

Dae Joong Im

Ki Ho Lee

Young-Sun Kang

Hyun-Seok Lee

Choon-Gil Kim

Eun-Ho Lee

Yong-Moon Choi

Dae-Joong Im

Bon-Chul Ku

The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: 

Aminocarbonylcarbamate compounds

There is provided a novel carbamoyloxy arylalkanoyl arylpiperazine derivative compound having abundant racemic or enantiomeric characteristics, represented by the Formula 1, and pharmaceutically available salts or hydrates thereof. Also, there are provided a pharmaceutical composition for treating pain, anxiety or depression including an effective amount of the compound, and a method for treating pain, anxiety or depression in mammals by administering an effective amount of the compound to the mammals in need of treatment thereof.

Method for treating pain, anxiety or depression using carbamoyloxy alkanoyl piperazine compound

Azole compounds containing carbamoyl group and pharmaceutically useful salts thereof are described. The compounds are effective anticonvulsants which are used in the treatment of disorders of the central nervous system, especially as anxiety, depression, convulsion, epilepsy, migraine, bipolar disorder, drug abuse, smoking, ADHD, obesity, sleep disorder, neuropathic pain, stroke, cognitive impairment, neurodegeneration, stroke and muscle spasm.

Neurotherapeutic azole compounds

Growing community of inventors

Daejeon, South Korea

Han-Ju Yi